Dr Teplinsky Oncologist - Search Videos

Dr. Eleonora Teplinsky highlights results from the phase 3 SERENA-6 trial that found switching to tx w camizestrant if an ESR1 mutation is detected during first-line treatment can help slow cancer growth for people w HR-positive, HER2-negative advanced breast cancer. Learn more: https://brnw.ch/21wT4Qr #bcsm #ASCO25 | American Society of Clinical Oncology

Dr. Eleonora Teplinsky highlights results from the phase 3 SERENA-6 trial that found switching to tx w camizestrant if an ESR1 mutation is detected during first-line treatment can help slow cancer growth for people w HR-positive, HER2-negative advanced breast cancer. Learn more: https://brnw.ch/21wT4Qr #bcsm #ASCO25 | American Society of Clinical Oncology

465 views10 months ago

FacebookAmerican Society of Clinical Oncology

What’s New in Breast Cancer Treatment? Dr. Eleonora Teplinsky at ASCO 2025

What’s New in Breast Cancer Treatment? Dr. Eleonora Teplinsky at ASCO 2025

1.6K views10 months ago

YouTubeMD Newsline

Breast Cancer Survivorship: Nutrition and Supplements

Breast Cancer Survivorship: Nutrition and Supplements

14.5K viewsFeb 21, 2023

YouTubeEleonora Teplinsky, MD

Let’s talk about #breastcancer risk assessment, the Tyrer Cuzick model, what it is, how to use it and more. #mammogram #oncologist | Eleonora Teplinsky, MD

Let’s talk about #breastcancer risk assessment, the Tyrer Cuzick model, what it is, how to use it and more. #mammogram #oncologist | Eleonora Teplinsky, MD

2.7K views2 months ago

FacebookEleonora Teplinsky, MD

Honest Answer About Oncology and Chemotherapy

Honest Answer About Oncology and Chemotherapy

18.1K viewsOct 7, 2022

TikTokdrteplinsky

Circulating tumor DNA in breast cancer. Sharing what it is, what it can tell us and significant limitations in its current use right now. Watch the video and please share your experiences with the test, questions about it, whether you’ve had it done, the conversations you’ve had around it and more! #breastcancer #signatera #oncologist | Eleonora Teplinsky, MD

Circulating tumor DNA in breast cancer. Sharing what it is, what it can tell us and significant limitations in its current use right now. Watch the video and please share your experiences with the test, questions about it, whether you’ve had it done, the conversations you’ve had around it and more! #breastcancer #signatera #oncologist | Eleonora Teplinsky, MD

32.3K views5 months ago

FacebookEleonora Teplinsky, MD

Do you need a full body #MRI to screen for #cancer? Short answer is no. Find out why in this video! #cancerscreening #oncologist #cancerdoctor

Do you need a full body #MRI to screen for #cancer? Short answer is no. Find out why in this video! #cancerscreening #oncologist #cancerdoctor

14.2K viewsJul 12, 2023

TikTokdrteplinsky

New study just published in JAMA Internal Medicine by Dr. Rebecca Smith-Bindman- CT scans are projected to account for 5% of cancers in the future from radiation exposure (given significant increase in how many CT scans are being done now compared to the past). These are projections but always important to make sure the study being done is medically necessary, consider alternative imaging if possible and make sure that the facility you go to to is accredited by the American College of Radiology

417 viewsApr 17, 2025

FacebookEleonora Teplinsky, MD

2026 Best of Breast - Cancer Survivorship - Eleanora Teplinsky, MD (Valley Health)

32 views2 months ago

YouTubeTotal Health | Oncology

Merry Christmas 🎄 and a post run chat on chemotherapy for premenopausal stage 1-3 HR /HER2- Breast Cancer and the OFSET clinical trial. This clinical trial is for premenopausal women with early-stage, hormone-receptor-positive, HER2-negative breast cancer and is investigating the benefit of chemotherapy standard hormonal (endocrine) therapy plus ovarian function suppression (OFS) versus endocrine therapy OFS (without chemo) for those with an Oncotype Recurrence Score (RS) up to 25. I go into mo

4.2K views4 months ago

FacebookEleonora Teplinsky, MD

Understanding Breast Cancer Risk with Dr. Teplinsky

1 views4 weeks ago

YouTubeFilthy Milfs Podcast

Another San Antonio Breast Cancer Symposium update - can we omit regional nodal radiation to patients with breast cancer who were lymph node positive at time of diagnosis and become lymph node negative after neoadjuvant chemotherapy. #breastcancer #radiation #radiationtherapy #oncology #oncologist #lymphnodebiopsy #cancerdoctor #chemo #breastcancersurvivor

6.1K viewsDec 10, 2023

TikTokdrteplinsky

Let’s talk about fear of cancer recurrence or progression. More than half of cancer survivors/thrivers experience this and it can cause emotional and physical distress, negatively impact quality of life and lead to hypervigilance or hypersensitivity of bodily symptoms. I share more in the video and talk about FCRI-SF, a tool available to screen for fear of cancer recurrence. You can find the tool at this link or google it. https://rb.gy/tn5y75 Let me know your experience with fear of cancer recu

9.4K viewsApr 19, 2024

TikTokdrteplinsky

Confused by all the treatment terms we’re using? You’re not alone. In this breakdown, Dr. Teplinsky walks through three key classes of medications used in hormone receptor–positive breast cancer: aromatase inhibitors (AIs), CDK4/6 inhibitors, and SERDs. These options play different roles in treatment today and new data is helping us understand how they may help patients in the future. Stay tuned for more from #SABCS25 coming soon! | The Breast Cancer Research Foundation

13.7K views4 months ago

FacebookThe Breast Cancer Research Foundation

⭐️ New breast cancer study! Comment DTC for link to the paper! One of the major challenges with breast cancer treatment is the risk of recurrence. Some cancer cells can travel to the bone marrow or other sites in the body and go into a dormant state. They are essentially hibernating and not active. At some point, they can “wake up” and a lot of research focuses on trying to figure out triggers (I recently shared a study on mice and how COVID and flu infections triggered dormant cells to reawaken

48.1K views7 months ago

FacebookEleonora Teplinsky, MD

Dr. Corinne Menn, DO, FACOG,MSCP on Instagram: "@isswshoffice 2026 Instructional Course: Conversations with the medical oncologists: Hormones after a breast cancer diagnosis. With Dr. Shari Goldfarb & Dr. Eleonora Teplinsky, moderated by Dr. Corinne Menn Vaginal hormones are safe for breast cancer patients and there are a variety of options and forms for patients to choose. No woman should suffer with GSM . Systemic hormone therapy questions are common and women want to be able to have real disc

77.2K views2 months ago

Instagramdrmennobgyn

What’s happening today at ASCO. #asco24 #cancer #oncologist

TikTokdrteplinsky

I read the Journal of Clinical Oncology every week (the journal of the American Society of Clinical Oncology). Let’s read this issue (Jan 20, 2026) together! In this video, I highlight these 3 articles: 1. Management of Cancer During Pregnancy: ASCO Guideline 2. Adjuvant Epirubicin Plus Cyclophosphamide Followed by Taxanes With or Without Carboplatin in Early-Stage Triple-Negative Breast Cancer (RJBC 1501): A Randomized Phase III Trial 3. Phase II Trial of Ribociclib Plus Letrozole in Women With

1K views2 months ago

TikTokdrteplinsky

Exciting news in metastatic breast cancer! We have three press releases from 3 major studies (one for each BC subtype: triple negative, HER2 positive and HR /HER2-) that may potentially transform first line treatment of MBC. These are just press releases and we don’t have full data yet but it is very exciting! The three studies are: 1. SERENA-6: Camizestrant for patients w HR /HER2- MBC on aromatase inhibitor CDK 4/6 inhibitor who develop an ESR1 mutation 2. Destiny-BREAST09: Enhertu Perjeta ver

7.3K viewsApr 24, 2025

FacebookEleonora Teplinsky, MD

Amy Comander MD, FACLM, DipABLM on Instagram: "Thank you to Dr. Eleonora Teplinsky for the beautiful video she shared yesterday which highlights our book “PAVING Your Path Through Breast Cancer and Beyond: Evidence-Based Lifestyle Medicine Tools for Cancer Survivorship.” Because of her video, our PAVING book is temporarily out of stock on Amazon! 😱I have been told this will be fixed soon, but for now you can place an order at www.healthylearning.com with the discount code PAVING25 for 25% off.

2.7K views3 months ago

Instagramdramycomander

I love seeing my patients getting great scan, pathology or lab results!! #oncology #oncologist #cancer #cancerdoctor

TikTokdrteplinsky

In Berlin for the ESMO 2025 Meeting and sharing a few breast cancer studies I am excited for that are being presented on Day 1, 10/17. Let me know which ones you are interested in and what other topics you want to hear about! #esmo25 #breastcancer #oncologist #cancer | Eleonora Teplinsky, MD

2.9K views6 months ago

FacebookEleonora Teplinsky, MD

Menopause and Cancer: What's the Truth? Our chat with Dr. Eleonora Teplinsky

17 views7 months ago

YouTubeNotYourMothersMenopause

Navigating Life After Breast Cancer: Insights from Survivors

2.5K views1 month ago

TikTokdrteplinsky

Understanding Breast Cancer Awareness with Eleonora Teplinsky

2K views6 months ago

TikToktheboobiedocs

One of the current gaps in current #breastcancer research is whether or not to do routine screening for brain metastases in patients with metastatic breast cancer who don’t have any concerning symptoms for brain metastases. Historically, we did not screen for brain metastases because therapies were toxic and we didn’t have good therapies but things are changing w better therapies (although we still have a way to go). This has raised the question of whether we should do brain imaging in people w

8.6K views5 months ago

FacebookEleonora Teplinsky, MD

SABCS 2023 Breast Cancer Highlights – NSABP B-51, IDEA Update, ICARO, Keynote 522 Update

2.9K viewsDec 15, 2023

YouTubeOncBrothers: Practice-Changing Cancer Discu…

Answering some of your questions about immunotherapy! Let me know what your experience has been with immunotherapy and any questions you might have. #immunotherapy #cancer #oncologist | Eleonora Teplinsky, MD

10.1K views6 months ago

FacebookEleonora Teplinsky, MD

Key facts about lobular carcinoma in situ (LCIS) and atypical ductal or lobular hyperplasia: ⭐️ What they are and how they increase breast cancer risk ⭐️ Do they need surgery? ⭐️ When do we think about endocrine therapy (tamoxifen or aromatase inhibitors) Bottom line: these are conditions that can increase your breast cancer risk in the future and we think about using endocrine therapy to lower that risk. Endocrine therapy can reduce risk of future breast cancer by 50% when given for LCIS or a

1.9K views8 months ago

FacebookEleonora Teplinsky, MD

Eleonora Teplinsky, MD | Cancer Doctor | Let’s talk about #DHEA (Intrarosa) in patients with #breastcancer for genitourinary syndrome of menopause. DHEA is produced primarily by... | Instagram

7.3K views2 months ago

Instagramdrteplinsky

See more